As with many of your courses, Biology 370 gets you out of the classroom and into the real world. We believe that students learn science best by doing science. At Hope, we provide new and interesting ...

Oct. 24, 2024 — A new study conducted in roundworms finds that a common plastic ingredient causes breaks in DNA strands, resulting in egg cells with the wrong number ...

Discover the applications of Ttau PFFs and alpha-synuclein PFFs in advancing neurodegenerative disease research.

Get here the five-month study routine for CBSE Class 10 Science, Maths, SST, English, Hindi, and Sanskrit, 2024-25 boards ...

During a Case-Based Roundtable® event, Ursa Brown-Glaberman, MD, discussed options for the treatment of patients with ...

The Rajasthan Public Service Commission has released the notification for School Lecturer Posts. A total of 2202 vacancies ...

JEE Main, starting from 2019, is now overseen by the National Testing Agency (NTA), taking over the responsibility from the ...

Yousef Zakharia, MD, discussed some of the available combination therapies for non–clear Cell renal cell carcinoma treatment.

Guo, Z. J. (2024). Study on the Grassroots Employment of College Students Majoring in Biology in Northern China. Open Journal of Social Sciences, 12, 41-53. doi: 10.4236/jss.2024.1210004 .

Global Plasmid Purification Market was valued at approximately USD 1.78 billion in 2023, exhibiting a robust CAGR of 11.69% throughout the forecast period from 2024 to 2032. Read the Market Summary ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOY™ (zolbetuximab-clzb) in combination ...

VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...